A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma
Recruiting · NCT06639347 · Registry updated 2024-11-18Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Trial of SHR-A2102 With Antitumor Therapy in Advanced Urothelial Carcinoma | Advanced Urothelial Carcinoma | Recruiting | Phase 1 / Phase 2 | 2024-11-18 | NCT06639347 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai Hengrui Pharmaceutical Co., Ltd. | 28 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Sun Yat-sen University Cancer Center | Guangzhou | China | 315 |